October 14, 2020 11:15 AM EDTUpdated 12:48 PM
News Briefing

News brief­ing: No­vo eyes the next ki­nas­es in a Finnish start­up; Boehringer In­gel­heim brings a bis­pe­cif­ic to the clin­ic

John Carroll

Editor & Founder

Jason Mast

Editor

No­vo Seeds’ Jeroen Bakker thinks he’s found the next ki­nas­es.

The ear­ly stage, Eu­ro­pean VC firm an­nounced yes­ter­day they led a $9 mil­lion seed round …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The brain is Eli Lil­ly's next tar­get for its obe­si­ty meds

The End­points 100: The biotech in­dus­try braces for Trump 2.0

Lil­ly’s oral SERD makes strides in breast can­cer with Phase 3 da­ta

Dur­ing Covid, RFK Jr. lob­bied against vac­cine EUAs for chil­dren. As HHS sec­re­tary, he could re­scind them

Drugs are ap­proved — and made avail­able — faster in US than most of EU, da­ta show

sponsored

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

A service from the Financial Times